Erik Hyypia
100%
The Daily's Verdict
This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.
Bias
No current examples available.
Conflicts of Interest
No current examples available.
Contradictions
No current examples available.
Deceptions
No current examples available.
Recent Articles
New TB Vaccine Trial Brings Hope to End the Pandemic in South Africa and Beyond
Broke On: Tuesday, 19 March 2024The Gates MRI has initiated a Phase 3 clinical trial to evaluate the effectiveness of the M72/AS01E vaccine candidate in protecting adolescents and adults from pulmonary tuberculosis. If successful, it could be the first new TB vaccine in over a century. The trial is significant as it brings hope for ending TB through prevention and early diagnosis.